相似文献
1
Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.
Nucleic Acids Res. 2010 Apr;38(6):2111-8. doi: 10.1093/nar/gkp1148. Epub 2009 Dec 8.
2
Cation Coordination Alters the Conformation of a Thrombin-Binding G-Quadruplex DNA Aptamer That Affects Inhibition of Thrombin.
Nucleic Acid Ther. 2016 Oct;26(5):299-308. doi: 10.1089/nat.2016.0606. Epub 2016 May 9.
3
Structure-Activity Relationship Study of a Potent α-Thrombin Binding Aptamer Incorporating Hexitol Nucleotides.
Chemistry. 2020 Aug 3;26(43):9589-9597. doi: 10.1002/chem.202001504. Epub 2020 Jul 9.
4
Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site.
Nucleic Acid Ther. 2019 Aug;29(4):208-217. doi: 10.1089/nat.2018.0757. Epub 2019 Mar 13.
5
Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer.
Nucleic Acids Res. 2018 Dec 14;46(22):12177-12185. doi: 10.1093/nar/gky990.
6
Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant.
J Control Release. 2016 Jan 10;221:9-17. doi: 10.1016/j.jconrel.2015.11.028. Epub 2015 Nov 28.
7
Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
J Thromb Haemost. 2008 Dec;6(12):2105-12. doi: 10.1111/j.1538-7836.2008.03162.x. Epub 2008 Sep 27.
8
Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
Nanomedicine. 2012 Jul;8(5):673-81. doi: 10.1016/j.nano.2011.08.011. Epub 2011 Sep 1.
9
Regulation of thrombin activity with a bifunctional aptamer and hemin: development of a new anticoagulant and antidote pair.
Chembiochem. 2009 Sep 4;10(13):2171-6. doi: 10.1002/cbic.200900408.
10
Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications.
Curr Pharm Des. 2012;18(14):2036-47. doi: 10.2174/138161212799958387.
引用本文的文献
1
Manipulating DNA and RNA structures via click-to-release caged nucleic acids for biological and biomedical applications.
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf571.
2
Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview.
Med Oncol. 2023 Dec 29;41(1):40. doi: 10.1007/s12032-023-02267-4.
3
Photocleavable -Nitrobenzyl-Protected DNA Architectures and Their Applications.
Chem Rev. 2023 May 24;123(10):6839-6887. doi: 10.1021/acs.chemrev.3c00016. Epub 2023 Apr 20.
4
Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine.
J Cancer Res Clin Oncol. 2023 Aug;149(10):7515-7527. doi: 10.1007/s00432-023-04698-y. Epub 2023 Mar 26.
5
Expanding Catch and Release DNA Decoy (CRDD) Technology with Pyrimidine Mimics.
Chemistry. 2022 Oct 18;28(58):e202201355. doi: 10.1002/chem.202201355. Epub 2022 Aug 25.
6
Controlling Coagulation in Blood with Red Light.
Angew Chem Int Ed Engl. 2021 Oct 4;60(41):22441-22446. doi: 10.1002/anie.202108468. Epub 2021 Aug 31.
7
Scoring Functions for Protein-RNA Complex Structure Prediction: Advances, Applications, and Future Directions.
Commun Inf Syst. 2020;20(1):1-22. doi: 10.4310/cis.2020.v20.n1.a1.
8
Covalent Bi-Modular Parallel and Antiparallel G-Quadruplex DNA Nanocostructs Reduce Viability of Patient Glioma Primary Cell Cultures.
Int J Mol Sci. 2021 Mar 25;22(7):3372. doi: 10.3390/ijms22073372.
9
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.
J Cancer. 2020 Oct 4;11(23):6902-6915. doi: 10.7150/jca.49532. eCollection 2020.
10
Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight.
Int J Mol Sci. 2020 May 29;21(11):3860. doi: 10.3390/ijms21113860.
本文引用的文献
1
Development of universal antidotes to control aptamer activity.
Nat Med. 2009 Oct;15(10):1224-8. doi: 10.1038/nm.1990. Epub 2009 Oct 4.
2
Using photons to manipulate enzyme inhibition by an azobenzene-modified nucleic acid probe.
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6489-94. doi: 10.1073/pnas.0812402106. Epub 2009 Apr 9.
3
The chemical biology of aptamers.
Angew Chem Int Ed Engl. 2009;48(15):2672-89. doi: 10.1002/anie.200804643.
4
Differential regulation of protein subdomain activity with caged bivalent ligands.
Chembiochem. 2009 Mar 2;10(4):654-7. doi: 10.1002/cbic.200800814.
5
Crystal structure of an RNA aptamer bound to thrombin.
RNA. 2008 Dec;14(12):2504-12. doi: 10.1261/rna.1239308. Epub 2008 Oct 29.
6
Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
J Thromb Haemost. 2008 Dec;6(12):2105-12. doi: 10.1111/j.1538-7836.2008.03162.x. Epub 2008 Sep 27.
7
Pegaptanib sodium for the treatment of age-related macular degeneration.
Expert Opin Pharmacother. 2008 Feb;9(3):499-508. doi: 10.1517/14656566.9.3.499.
8
Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer.
Chembiochem. 2007 Dec 17;8(18):2223-6. doi: 10.1002/cbic.200700535.
9
Light-dependent RNA interference with nucleobase-caged siRNAs.
RNA. 2007 Dec;13(12):2341-7. doi: 10.1261/rna.753407. Epub 2007 Oct 19.
10
Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.
Chem Rev. 2007 Sep;107(9):3715-43. doi: 10.1021/cr0306743. Epub 2007 Aug 23.
Zotero 插件
